Performance vs S&P 500

03
Tracked Q1 2025–Q3 2025 +37.0%
S&P 500 total return (same window) +21.3%
Excess return +15.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

04
Healthcare 100.0%

Full portfolio 1 positions

05
Type Streak 8Q trend
MGX Metagenomi Therapeutics, Inc. - Common Stock $1,331,404 100.00% 581,577 $470,670

Top movers (QoQ)

10
SecurityActionShares ΔValue Δ
MGX Price move only +0 +$471K